Skip to main content

Table 1 Schedule of enrollment, interventions and assessments

From: The effects of linagliptin on endothelial function and global arginine bioavailability ratio in coronary artery disease patients with early diabetes: study protocol for a randomized controlled trial

  1. sVCAM-1 Soluble Vascular Cell Adhesion Molecule-1, sICAM-1 soluble Intercellular Adhesion Molecule-1